
Eric Olson
Examiner (ID: 15792, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1673, 1623, 1693 |
| Total Applications | 1700 |
| Issued Applications | 960 |
| Pending Applications | 118 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11657249
[patent_doc_number] => 09670238
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-06-06
[patent_title] => '5′-dibenzyl phosphates of 5-azacytidine or 2′-deoxy-5-azacytidine'
[patent_app_type] => utility
[patent_app_number] => 15/355326
[patent_app_country] => US
[patent_app_date] => 2016-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6403
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15355326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/355326 | 5′-dibenzyl phosphates of 5-azacytidine or 2′-deoxy-5-azacytidine | Nov 17, 2016 | Issued |
Array
(
[id] => 11704560
[patent_doc_number] => 20170173059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'Novel Combination of Naturally Occurring Compounds to Assist With Suspected Mycobacterial Infections Related to Autoimmune Conditions'
[patent_app_type] => utility
[patent_app_number] => 15/354975
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11665
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354975
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354975 | Novel Combination of Naturally Occurring Compounds to Assist With Suspected Mycobacterial Infections Related to Autoimmune Conditions | Nov 16, 2016 | Abandoned |
Array
(
[id] => 14406759
[patent_doc_number] => 20190169223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => OLIGONUCLEOTIDE PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 15/776709
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15776709
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/776709 | Oligonucleotide production method | Nov 16, 2016 | Issued |
Array
(
[id] => 15068555
[patent_doc_number] => 10463743
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/352256
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 23
[patent_no_of_words] => 12506
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15352256
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/352256 | Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof | Nov 14, 2016 | Issued |
Array
(
[id] => 14454301
[patent_doc_number] => 10323103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Alkylated cyclodextrin compositions and processes for preparing and using the same
[patent_app_type] => utility
[patent_app_number] => 15/351272
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 28843
[patent_no_of_claims] => 139
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351272
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351272 | Alkylated cyclodextrin compositions and processes for preparing and using the same | Nov 13, 2016 | Issued |
Array
(
[id] => 11972516
[patent_doc_number] => 20170276671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'RECEPTOR LINKED REGENERATED CELLULOSE MEMBRANE AND METHODS FOR PRODUCING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/504647
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11602
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/504647 | RECEPTOR LINKED REGENERATED CELLULOSE MEMBRANE AND METHODS FOR PRODUCING AND USING THE SAME | Nov 13, 2016 | Abandoned |
Array
(
[id] => 14388443
[patent_doc_number] => 10307479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Therapy-enhancing glucan
[patent_app_type] => utility
[patent_app_number] => 15/338805
[patent_app_country] => US
[patent_app_date] => 2016-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 39
[patent_no_of_words] => 22076
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338805 | Therapy-enhancing glucan | Oct 30, 2016 | Issued |
Array
(
[id] => 18260691
[patent_doc_number] => 11608385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Alternative post treatment for stabilizing highly disordered celluloses
[patent_app_type] => utility
[patent_app_number] => 15/337302
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5784
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337302 | Alternative post treatment for stabilizing highly disordered celluloses | Oct 27, 2016 | Issued |
Array
(
[id] => 16443641
[patent_doc_number] => 10835545
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Synthetic composition and method for modulating brain function and behaviour
[patent_app_type] => utility
[patent_app_number] => 15/771189
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5669
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771189 | Synthetic composition and method for modulating brain function and behaviour | Oct 27, 2016 | Issued |
Array
(
[id] => 11555237
[patent_doc_number] => 20170101484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR MAKING ALPHA-(1,2)-BRANCHED ALPHA-(1,6) OLIGODEXTRANS'
[patent_app_type] => utility
[patent_app_number] => 15/331223
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16244
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15331223
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/331223 | Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans | Oct 20, 2016 | Issued |
Array
(
[id] => 17814272
[patent_doc_number] => 11419859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Combination therapy for treating malignancies
[patent_app_type] => utility
[patent_app_number] => 15/767813
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29228
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767813
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767813 | Combination therapy for treating malignancies | Oct 13, 2016 | Issued |
Array
(
[id] => 11400366
[patent_doc_number] => 20170020905
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER'
[patent_app_type] => utility
[patent_app_number] => 15/288152
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11077
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288152
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288152 | COMPOSITIONS AND METHODS FOR TREATING AN AGGREGATION DISEASE OR DISORDER | Oct 6, 2016 | Abandoned |
Array
(
[id] => 11567456
[patent_doc_number] => 20170106100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-20
[patent_title] => 'CYCLODEXTRINS WITH ONE OR MORE POLY(ETHYLENE GLYCOL) UNITS, INCLUSION COMPOUNDS AND DRUG DELIVERY VEHICLES INCLUDING THE SAME, AND METHODS OF MAKING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/286454
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 12938
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15286454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/286454 | Cyclodextrins with one or more poly(ethylene glycol) units, inclusion compounds and drug delivery vehicles including the same, and methods of making and using the same | Oct 4, 2016 | Issued |
Array
(
[id] => 11381650
[patent_doc_number] => 20170007706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'Sialic Acid Derivatives For Protein Derivatisation And Conjugation'
[patent_app_type] => utility
[patent_app_number] => 15/276471
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12347
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15276471
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/276471 | Sialic acid derivatives for protein derivatisation and conjugation | Sep 25, 2016 | Issued |
Array
(
[id] => 13504633
[patent_doc_number] => 20180303859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Agent For Preventing And/Or Treating Scleroderma
[patent_app_type] => utility
[patent_app_number] => 15/763527
[patent_app_country] => US
[patent_app_date] => 2016-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763527
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763527 | Agent For Preventing And/Or Treating Scleroderma | Sep 25, 2016 | Abandoned |
Array
(
[id] => 14975317
[patent_doc_number] => 10441541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Methods and compositions for treating osteoarthritis and promoting cartilage formation
[patent_app_type] => utility
[patent_app_number] => 15/262372
[patent_app_country] => US
[patent_app_date] => 2016-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 54
[patent_no_of_words] => 19045
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15262372
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/262372 | Methods and compositions for treating osteoarthritis and promoting cartilage formation | Sep 11, 2016 | Issued |
Array
(
[id] => 11348845
[patent_doc_number] => 20160367585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'NOVEL AMINOGLYCOSIDE ANTIBIOTICS, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/257158
[patent_app_country] => US
[patent_app_date] => 2016-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6447
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15257158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/257158 | NOVEL AMINOGLYCOSIDE ANTIBIOTICS, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF | Sep 5, 2016 | Abandoned |
Array
(
[id] => 15538259
[patent_doc_number] => 10568887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Combination therapies for treatment of cancer
[patent_app_type] => utility
[patent_app_number] => 15/750151
[patent_app_country] => US
[patent_app_date] => 2016-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 7545
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15750151
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/750151 | Combination therapies for treatment of cancer | Aug 2, 2016 | Issued |
Array
(
[id] => 11400308
[patent_doc_number] => 20170020846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING THE GROWTH OF MULTI-DRUG RESISTANT MICROBES'
[patent_app_type] => utility
[patent_app_number] => 15/214781
[patent_app_country] => US
[patent_app_date] => 2016-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6778
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15214781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/214781 | Compositions and methods for inhibiting the growth of multi-drug resistant microbes | Jul 19, 2016 | Issued |
Array
(
[id] => 12136989
[patent_doc_number] => 20180015072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'Tryptophan is a pro-drug for infectious diseases and cancers'
[patent_app_type] => utility
[patent_app_number] => 15/208586
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1153
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208586
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208586 | Tryptophan is a pro-drug for infectious diseases and cancers | Jul 11, 2016 | Abandoned |